GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 32 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $26,000 | – | 4,629 | +10186.7% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 45 | -99.9% | 0.00% | – |
| Q2 2019 | $237,000 | -11.2% | 32,300 | -1.5% | 0.00% | – |
| Q1 2019 | $267,000 | +16.6% | 32,800 | -2.4% | 0.00% | – |
| Q4 2018 | $229,000 | -42.5% | 33,600 | -53.1% | 0.00% | – |
| Q1 2018 | $398,000 | +61.8% | 71,585 | +165.6% | 0.00% | – |
| Q4 2017 | $246,000 | +969.6% | 26,949 | +418.2% | 0.00% | – |
| Q2 2016 | $23,000 | -20.7% | 5,200 | +65.7% | 0.00% | – |
| Q1 2015 | $29,000 | -85.1% | 3,139 | -84.3% | 0.00% | – |
| Q2 2014 | $194,000 | -15.3% | 20,000 | 0.0% | 0.00% | – |
| Q1 2014 | $229,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 202,100 | $2,318,000 | 1.99% |
| Gerry Farber, LLC | 52,000 | $596,000 | 1.03% |
| Granite Point Capital Management, L.P. | 115,000 | $1,319,000 | 0.94% |
| 683 Capital Management, LLC | 158,735 | $1,821,000 | 0.71% |
| SPHERA FUNDS MANAGEMENT LTD. | 170,000 | $1,950,000 | 0.44% |
| Knoll Capital Management, LLC | 65,000 | $746,000 | 0.39% |
| Healthcare Value Capital, LLC | 50,000 | $574,000 | 0.38% |
| Park West Asset Management LLC | 200,000 | $2,294,000 | 0.26% |
| Perceptive Advisors | 75,000 | $860,000 | 0.09% |
| HIGHLAND CAPITAL MANAGEMENT LP | 126,956 | $1,456,000 | 0.06% |